USA - NASDAQ:HYFT - CA45257F2008 - Common Stock
The current stock price of HYFT is 1.8 USD. In the past month the price increased by 13.21%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.02 | 198.56B | ||
DHR | DANAHER CORP | 27.38 | 147.61B | ||
BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.42 | 43.85B | ||
A | AGILENT TECHNOLOGIES INC | 25.33 | 39.13B | ||
IQV | IQVIA HOLDINGS INC | 17.85 | 34.81B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.86 | 26.84B | ||
WAT | WATERS CORP | 27.24 | 19.83B | ||
WST | WEST PHARMACEUTICAL SERVICES | 37.52 | 18.78B | ||
TEM | TEMPUS AI INC | N/A | 15.61B | ||
MEDP | MEDPACE HOLDINGS INC | 38.43 | 14.52B | ||
ICLR | ICON PLC | 14.05 | 14.46B | ||
ILMN | ILLUMINA INC | 21.88 | 13.99B |
ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The company is headquartered in Austin, Texas. The company is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. The company is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.
MINDWALK HOLDINGS CORP
Industrious 823 Congress Ave Suite 300
Austin TEXAS US
Employees: 102
Phone: 16048060626
The current stock price of HYFT is 1.8 USD. The price decreased by -5.26% in the last trading session.
The exchange symbol of MINDWALK HOLDINGS CORP is HYFT and it is listed on the Nasdaq exchange.
HYFT stock is listed on the Nasdaq exchange.
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 1.8. Check the MINDWALK HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MINDWALK HOLDINGS CORP (HYFT) has a market capitalization of 83.09M USD. This makes HYFT a Micro Cap stock.
MINDWALK HOLDINGS CORP (HYFT) currently has 102 employees.
MINDWALK HOLDINGS CORP (HYFT) has a support level at 1.77 and a resistance level at 1.82. Check the full technical report for a detailed analysis of HYFT support and resistance levels.
The Revenue of MINDWALK HOLDINGS CORP (HYFT) is expected to decline by -29.75% in the next year. Check the estimates tab for more information on the HYFT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HYFT does not pay a dividend.
MINDWALK HOLDINGS CORP (HYFT) will report earnings on 2025-12-08.
MINDWALK HOLDINGS CORP (HYFT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
The outstanding short interest for MINDWALK HOLDINGS CORP (HYFT) is 1.08% of its float. Check the ownership tab for more information on the HYFT short interest.
ChartMill assigns a technical rating of 4 / 10 to HYFT.
ChartMill assigns a fundamental rating of 2 / 10 to HYFT. HYFT may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months HYFT reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 54.47% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -71.65% | ||
ROE | -140.74% | ||
Debt/Equity | 0.16 |
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 1.8.
For the next year, analysts expect an EPS growth of 40.5% and a revenue growth -29.75% for HYFT